MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$20,000K
Net Income
-$20,908K
Net Profit Margin
-104.54%
EPS
-$0.42
Unit: Thousand (K) dollars
Income Statement
2026-03-31
2025-09-30
2025-06-30
Collaboration revenue
20,000
-
-
Research and development
32,716
22,279
22,680
General and administrative
-
7,707
6,816
Selling, general and administrative
11,499
-
-
Total operating expenses
44,215
29,986
29,496
Loss from operations
-24,215
-29,986
-29,496
Interest income
4,358
3,061
2,764
Total other income, net
4,358
3,061
2,764
Net loss
-19,857
-26,925
-26,732
Change in unrealized gains (losses) on investments, net of tax
-1,051
221
19
Total other comprehensive income (loss)
-1,051
221
19
Comprehensive loss
-20,908
-26,704
-26,713
Basic EPS
-0.42
-0.71
-0.75
Diluted EPS
-0.42
-0.71
-0.75
Basic Average Shares
47,236,618
37,931,170
35,444,635
Diluted Average Shares
47,236,618
37,931,170
35,444,635
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

RAPP Income Statement Sankey DiagramSankey diagram visualizing RAPP income statement for the periodComprehensive loss-$20,908K Interest income$4,358K Net loss-$19,857K Total othercomprehensive income (loss)-$1,051K Total other income,net$4,358K Loss from operations-$24,215K Change in unrealizedgains (losses) on...-$1,051K Collaboration revenue$20,000K Total operatingexpenses$44,215K Research and development$32,716K Selling, general andadministrative$11,499K

Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics, Inc. (RAPP)